Skip to content
10-K

Annual Report

BioCorRx Inc. BICX

0001477932-24-001705

← back to feed
Filed
Apr 1, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 29, 2024 8.82M sh
Shares Diluted FY 2023 · Dec 31, 2022 1.45M sh
Operating Cash Flow FY 2023 · Dec 31, 2022 −$2.04M
Operating Cash Flow FY 2023 · Sep 30, 2022 −$1.59M
Stockholders Equity restated FY 2023 · Dec 31, 2022 −$8.08M
Current Liabilities FY 2023 · Dec 31, 2022 $5.36M
Total Liabilities FY 2023 · Dec 31, 2022 $8.97M
Current Assets FY 2023 · Dec 31, 2022 $316.91K
Total Assets FY 2023 · Dec 31, 2022 $766.59K
Sga Expense FY 2023 · Dec 31, 2022 $3.41M
Rd Expense FY 2023 · Dec 31, 2022 $1.46M
Net Income FY 2023 · Dec 31, 2022 −$4.38M
Operating Income FY 2023 · Dec 31, 2022 −$4.7M
Cost Of Revenue FY 2023 · Dec 31, 2022 $15.28K
Revenue FY 2023 · Dec 31, 2022 $213.84K